Good news anyway. Pretty light on of late IMO. At the AGM, I think the Chair indicated 70% recruitment but didn't really get any confirmation from PW. I looked at the trial site yesterday and they are recruiting at 30 centres in USA and Europe. So I was encouraged and they have come through. Don't expect a lot of market response as commercial revenue some time away with hurdles to cross. Nonetheless good news. Really need some indication of revenue boost in the near term with Scenesse expansion, photocosmetics or ACTH with the latter 2 still some time away it seems. There's always a surprise like a company acquisition or buyback but they seem a tad imaginary?? GLTA
Ann: CUV recruits 200 patients in Phase III vitiligo trial CUV105, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.51 |
Change
0.400(3.30%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| $12.05 | $12.59 | $12.00 | $1.416M | 114.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $12.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 849 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |